These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10612590)

  • 1. Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings.
    Ohkubo M; Nishimura T; Honma T; Nishimura I; Ito S; Yoshinari T; Suda HA; Morishima H; Nishimura S
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3307-12. PubMed ID: 10612590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of NB-506 analogues modified at the glucose group.
    Ohkubo M; Nishimura T; Kawamoto H; Nakano M; Honma T; Yoshinari T; Arakawa H; Suda H; Morishima H; Nishimura S
    Bioorg Med Chem Lett; 2000 Mar; 10(5):419-22. PubMed ID: 10743939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506.
    Ohkubo M; Kojiri K; Kondo H; Tanaka S; Kawamoto H; Nishimura T; Nishimura I; Yoshinari T; Arakawa H; Suda H; Morishima H; Nishimura S
    Bioorg Med Chem Lett; 1999 May; 9(9):1219-24. PubMed ID: 10340602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.
    Saulnier MG; Balasubramanian BN; Long BH; Frennesson DB; Ruediger E; Zimmermann K; Eummer JT; St Laurent DR; Stoffan KM; Naidu BN; Mahler M; Beaulieu F; Bachand C; Lee FY; Fairchild CR; Stadnick LK; Rose WC; Solomon C; Wong H; Martel A; Wright JJ; Kramer R; Langley DR; Vyas DM
    J Med Chem; 2005 Apr; 48(7):2258-61. PubMed ID: 15801816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
    Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
    Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NB 506].
    Lansiaux A; Bailly C
    Bull Cancer; 1999 Mar; 86(3):255-8. PubMed ID: 10210758
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and antitumor evaluation of benzopsoralen analogues.
    Oliveira AM; Oliveira-Campos AM; Rodrigues LM; Raposo MM; Machado AE; Nascimento MS; Nazareth N; Pinto M
    Chem Biodivers; 2007 May; 4(5):980-90. PubMed ID: 17510993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model.
    Balasubramanian BN; St Laurent DR; Saulnier MG; Long BH; Bachand C; Beaulieu F; Clarke W; Deshpande M; Eummer J; Fairchild CR; Frennesson DB; Kramer R; Lee FY; Mahler M; Martel A; Naidu BN; Rose WC; Russell J; Ruediger E; Solomon C; Stoffan KM; Wong H; Wright JJ; Zimmermann K; Vyas DM
    J Med Chem; 2004 Mar; 47(7):1609-12. PubMed ID: 15027851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
    Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
    Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110.
    Zembower DE; Zhang H; Lineswala JP; Kuffel MJ; Aytes SA; Ames MM
    Bioorg Med Chem Lett; 1999 Jan; 9(2):145-50. PubMed ID: 10021917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
    Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
    Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
    Conchon E; Anizon F; Aboab B; Prudhomme M
    J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activity of benzocyclobutacarbazol derivatives. A new class of potential antitumor agents.
    Graf-Christophe S; Kuehm-Caubère C; Renard P; Pfeiffer B; Pierré A; Léonce S; Caubère P
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2589-91. PubMed ID: 11128630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first synthesis of clausenamine-A and cytotoxic activities of three biscarbazole analogues against cancer cells.
    Zhang A; Lin G
    Bioorg Med Chem Lett; 2000 May; 10(10):1021-3. PubMed ID: 10843207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.
    Zhang G; Shen J; Cheng H; Zhu L; Fang L; Luo S; Muller MT; Lee GE; Wei L; Du Y; Sun D; Wang PG
    J Med Chem; 2005 Apr; 48(7):2600-11. PubMed ID: 15801850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.
    Chao WR; Yean D; Amin K; Green C; Jong L
    J Med Chem; 2007 Jul; 50(15):3412-5. PubMed ID: 17602463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl'-D-glucopyranosides.
    Shi H; Zhou B; Li W; Shi Z; Yu B; Wang R
    Bioorg Med Chem Lett; 2010 May; 20(9):2855-8. PubMed ID: 20356741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticancer activity of new 1-substituted-6H-pyrido[4,3-b]carbazole derivatives.
    Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Wietrzyk J
    Arch Pharm (Weinheim); 2008 Jun; 341(6):351-6. PubMed ID: 18404778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.